-
1
المؤلفون: Lea Ladegaard Grønkjær, Mette Munk Lauridsen
المصدر: JHEP Reports, Vol 3, Iss 6, Pp 100370-(2021)
Grønkjær, L L & Lauridsen, M M 2021, ' Quality of life and unmet needs in patients with chronic liver disease : A mixed-method systematic review ', JHEP Reports, vol. 3, no. 6, 100370 . https://doi.org/10.1016/j.jhepr.2021.100370Test
JHEP Reportsمصطلحات موضوعية: PBC, Primary Biliary Cholangitis Questionnaire, Patient experience, Quality of life, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, NASH, non-alcoholic steatohepatitis, VAS, visual analogue scale, Population, EQ-5D, European Quality of Life, FACT-Hep, Functional Assessment of Cancer Therapy Hepatobiliary Carcinoma, HBQOL, Hepatitis B Quality of Life, Disease, CINAHL, RC799-869, Chronic liver disease, SIP, Sickness Impact Profile, Unmet needs, MELD, model for end-stage liver disease, Liver disease, CLDQ, Chronic Liver Disease Questionnaire, LC-PROM, Liver Cirrhosis Patient Reported Outcome Measure, Quality of life (healthcare), Internal Medicine, medicine, Immunology and Allergy, Intensive care medicine, education, PedsQL, Pediatric Quality of Life Inventory, Patient reported outcomes, education.field_of_study, Hepatology, WHOQOL-BREF, WHO Quality of Life, business.industry, JBI, Joanna Briggs Institute, Gastroenterology, Diseases of the digestive system. Gastroenterology, medicine.disease, SF, Short Form, Mixed method, Systematic review, business, HCC, hepatocellular carcinoma, Research Article, LDQOL, Liver Disease Quality of Life
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5347f777d34d635854930477dc42eccfTest
http://www.sciencedirect.com/science/article/pii/S2589555921001464Test -
2
المؤلفون: Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley
المساهمون: Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health
المصدر: JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BVمصطلحات موضوعية: NASH, non-alcoholic steatohepatiti, Y GASTRIC BYPASS, Disease, RC799-869, PLACEBO-CONTROLLED TRIAL, LIFE-STYLE MODIFICATION, cardiovascular disease, LDL, low-density lipoprotein, HEPATOCELLULAR-CARCINOMA, non-invasive test, T2D, GLP-1 RAs, glucagon-like receptor 1 agonists, European Association for the Study of Obesity, HCC, Gastroenterology, NASH, specific, Diseases of the digestive system. Gastroenterology, CAP, controlled attenuation parameter, CT, computed tomography, FXR, ASH, alcoholic steatohepatitis, GP, non-alcoholic steatohepatitis, GLP-1 RAs, glucagon-like receptor 1 agonist, LDL, low-density lipoproteins, medicine.medical_specialty, HDL, achievable, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, high-density lipoprotein, CVD, cardiovascular disease, LDL, Patient Guideline, Quality of life (healthcare), FXR, farnesoid X receptor, NAFLD, low-density lipoproteins, GP, general practitioner, NAFL, non-alcoholic fatty liver, FIB-4, fibrosis-4 index, Intensive care medicine, computed tomography, Guideline, medicine.disease, T1D, type 1 diabete, digestive system diseases, NIT, Human medicine, farnesoid X receptor, type 1 diabetes, BMI, body mass index, EASL, European Association for the Study of the Liver, Placebo-controlled study, Chronic liver disease, GLP-1 RAs, QUALITY-OF-LIFE, alcoholic steatohepatitis, European Association for the Study of Diabetes, EASD, European Association for the Study of Diabetes, Immunology and Allergy, magnetic resonance imaging, NASH Clinical Research Network, ALD, alcohol-related or alcoholic liver disease, Disease management (health), glucagon-like receptor 1 agonists, EASO, European Association for the Study of Obesity, NASH CRN, NASH Clinical Research Network, ASH, alcoholic steatohepatiti, Fatty liver, timely, hepatocellular carcinoma, CVD, magnetic resonance elastography, MRE, NAFL, FIB-4, non-alcoholic fatty liver, type 2 diabetes, T1D, type 1 diabetes, CAP, controlled attenuation parameter, CT, European Association for the Study of the Liver, MRI, fibrosis-4 index, NAFLD, non-alcoholic fatty liver disease, EASD, HDL, high-density lipoprotein, UNITED-STATES, ASH, body mass index, EASL, measurable, BMI, NIT, non-invasive test, Internal Medicine, medicine, NASH CRN, HEPATIC STEATOSIS, HCC, hepatocellular carcinoma, MRE, magnetic resonance elastography, MRI, magnetic resonance imaging, SMART, specific, measurable, achievable, relevant, timely, Disease burden, BARIATRIC SURGERY, Hepatology, SMART, business.industry, SERUM ALANINE AMINOTRANSFERASE, non-alcoholic fatty liver disease, PHYSICAL-ACTIVITY, alcohol-related or alcoholic liver disease, EASD, European Association for the Study of Diabete, EASO, ALD, general practitioner, relevant, T1D, business
وصف الملف: ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1Test
https://pubmed.ncbi.nlm.nih.gov/34693236Test -
3
المؤلفون: Lucia Parlati, Catherine Postic, Marion Régnier, Hervé Guillou
المساهمون: LESUR, Hélène, Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance - - HepAdialogue2017 - ANR-17-CE14-0015 - AAPG2017 - VALID, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Catholique de Louvain = Catholic University of Louvain (UCL), ToxAlim (ToxAlim), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Ecole d'Ingénieurs de Purpan (INPT - EI Purpan), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Toxicologie Intégrative & Métabolisme (ToxAlim-TIM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Toulouse III - Paul Sabatier (UT3), Lucia Parlati and Catherine Postic received funding from the French association for the study of the liver (AFEF). Catherine Postic and Herve Guillou received funding from the Agence Nationale de la Recherche (ANR-17-CE14-0015Hepadialogue)., ANR-17-CE14-0015,HepAdialogue,Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance(2017), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)
المصدر: JHEP Reports
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩مصطلحات موضوعية: HFD, high-fat diet, SREBP-1c, [SDV]Life Sciences [q-bio], Disease, Review, ACC, acetyl-CoA carboxylase, ASK1, apoptosis signal-regulating kinase 1, Chronic liver disease, Bioinformatics, ChREBP, carbohydrate responsive element–binding protein, PPARα, NEFA, TNF-α, tumour necrosis factor-α, 0302 clinical medicine, Fibrosis, Immunology and Allergy, Medicine, IL-, interleukin, VLDL, very low-density lipoprotein, 0303 health sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, NEFA, non-esterified fatty acid, Fatty liver, Gastroenterology, NASH, lipotoxicity, FAS, fatty acid synthase, animal models, 3. Good health, [SDV] Life Sciences [q-bio], PY, persons/years, Lipotoxicity, FXR, Saturated fatty acid, JNK, c-Jun N-terminal kinase, 030211 gastroenterology & hepatology, LXR, CAP, controlled attenuation parameter, HSL, hormone-sensitive lipase, HSC, hepatic stellate cells, GGT, gamma glutamyltransferase, NAFLD, non-alcoholic fatty liver disease, ChREBP, NASH, non-alcoholic steatohepatitis, SFA, saturated fatty acid, TCA, tricarboxylic acid, Phf2, histone demethylase plant homeodomain finger 2, digestive system, 03 medical and health sciences, glucotoxicity, FXR, farnesoid X receptor, NAFLD, FFA, free fatty acid, Internal Medicine, RCT, randomised controlled trial, Liver X receptor, PPARa, 030304 developmental biology, FGF21, fibroblast growth factor-21, MCD, methionine- and choline-deficient, HVPG, hepatic venous pressure gradient, Hepatology, business.industry, PUFAs, polyunsaturated fatty acids, nutritional and metabolic diseases, TLR4, Toll-like receptor 4, SCD1, stearoyl-CoA desaturase-1, medicine.disease, digestive system diseases, PPARα, peroxisome proliferator-activated receptor-α, SREBP-1c, sterol regulatory element–binding protein-1c, Steatosis, LXR, liver X receptor, business, HCC, hepatocellular carcinoma, MUFA, monounsaturated fatty acids, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba31673956635c337dc60791ff712432Test
https://pubmed.ncbi.nlm.nih.gov/34667947Test -
4
المؤلفون: Manuel Romero-Gómez, Patrizia Carrieri, Mattias Ekstedt, Shira Zelber-Sagi, Katja Novak, Vlad Ratziu, Quentin M. Anstee, Frank Tacke, Adam Palayew, Jeffrey V. Lazarus, Helena Cortez-Pinto, Giulio Marchesini
المساهمون: Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), University of Barcelona, McGill University = Université McGill [Montréal, Canada], Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Linköping University (LIU), Alma Mater Studiorum University of Bologna (UNIBO), Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria 'San Martino' (IRCCS AOU San Martino), University Medical Centre Ljubljana [Ljubljana, Slovenia] (UMCL), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Liver Unit, Clínica Universitaria, CIBER-EHD, Hospital Universitario Virgen del Rocío [Sevilla], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], University of Haifa [Haifa], Universidade de Lisboa (ULISBOA), Newcastle University [Newcastle], Lazarus J.V., Palayew A., Carrieri P., Ekstedt M., Marchesini G., Novak K., Ratziu V., Romero-Gomez M., Tacke F., Zelber-Sagi S., Cortez-Pinto H., Anstee Q.M., EASL International Liver Foundation, Gilead Sciences, Allergan Foundation, Bristol-Myers Squibb, Pfizer, Resoundant, Intercept Pharmaceuticals, Genfit, Ministerio de Ciencia, Innovación y Universidades (España), Instituto de Salud Carlos III, European Commission, Generalitat de Catalunya, NIHR Biomedical Research Centre (UK), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Universidade de Lisboa = University of Lisbon (ULISBOA), Repositório da Universidade de Lisboa, Gestionnaire, Hal Sorbonne Université
المصدر: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100234. ⟨10.1016/j.jhepr.2021.100234⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100234-(2021)مصطلحات موضوعية: ESPEN, type 2 diabetes mellitus, EASL, European Association for the Study of the Liver, [SDV]Life Sciences [q-bio], Disease, Multiple joint correspondence analysi, WHO, 0302 clinical medicine, Non-alcoholic fatty liver disease, Liver health, Multiple joint correspondence analysis, Policy preparedness, Health policy, Metabolic-associated fatty liver disease, Non-alcoholic steatohepatitis, Europe, Multidisciplinary approach, EASD, European Association for the Study of Diabetes, European Association for the Study of Diabetes, Epidemiology, Immunology and Allergy, Medicine, European Association for the Study of Obesity, European Society of Clinical Nutrition and Metabolism, EEA, EASO, European Association for the Study of Obesity, media_common, Gastroenterology, NASH, food and beverages, ESPEN, European Society of Clinical Nutrition and Metabolism, 3. Good health, [SDV] Life Sciences [q-bio], 030220 oncology & carcinogenesis, Preparedness, 030211 gastroenterology & hepatology, Research Article, European Association for the Study of the Liver, EEA, European Economic Area, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, EASD, NASH, non-alcoholic steatohepatitis, multiple correspondence analysis, T2DM, Gastroenterology and Hepatology, EASL, World Health Organization, digestive system, WHO, World Health Organization, European Economic Area, 03 medical and health sciences, Environmental health, EU, European Union, NAFLD, Gastroenterologi, Internal Medicine, media_common.cataloged_instance, European Union, lcsh:RC799-869, European union, MCA, multiple correspondence analysis, Hepatology, business.industry, Public health, MCA, nutritional and metabolic diseases, non-alcoholic fatty liver disease, T2DM, type 2 diabetes mellitus, medicine.disease, Obesity, digestive system diseases, EASO, lcsh:Diseases of the digestive system. Gastroenterology, business, EU, Non-alcoholic steatohepatiti
وصف الملف: ELETTRONICO; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237265ca3a905978c88b2731dd069191Test
https://hal.sorbonne-universite.fr/hal-03174867Test -
5
المؤلفون: Linda Henry, Zobair M. Younossi
المصدر: JHEP Reports
مصطلحات موضوعية: medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, Cirrhosis, STAT3, signal transducer and activator of transcription 3, NASH, non-alcoholic steatohepatitis, Context (language use), Disease, Type 2 diabetes, Review, CVD, cardiovascular disease, Gastroenterology, digestive system, ELF, enhanced liver fibrosis, PDGF, platelet-derived growth factor, Internal medicine, Epidemiology, Internal Medicine, Immunology and Allergy, Medicine, awareness, FIB-4, fibrosis-4, ALD, alcohol-related liver disease, neoplasms, Hepatology, business.industry, cirrhosis, Fatty liver, nutritional and metabolic diseases, non-cirrhosis, medicine.disease, Obesity, VEGF, vascular endothelial growth factor, digestive system diseases, natural history, Hepatocellular carcinoma, surveillance, business, HCC, hepatocellular carcinoma, TNF, tumour necrosis factor-α
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4964dc0d86470071e38394d6df7fbTest
https://pubmed.ncbi.nlm.nih.gov/34189448Test -
6
المؤلفون: Daniel G.K. Rasmussen, Peder Frederiksen, Diana Julie Leeming, Lise Lotte Gluud, Elisabeth Erhardtsen, Jörn M. Schattenberg, Diane E. Shevell, M.A. Karsdal, Guruprasad P. Aithal
المصدر: Erhardtsen, E, Rasmussen, D G K, Frederiksen, P, Leeming, D J, Shevell, D, Gluud, L L, Karsdal, M A, Aithal, G P & Schattenberg, J M 2021, ' Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis ', JHEP Reports, vol. 3, no. 4, 100317 . https://doi.org/10.1016/j.jhepr.2021.100317Test
JHEP Reports, Vol 3, Iss 4, Pp 100317-(2021)
JHEP Reportsمصطلحات موضوعية: NASH-CRN, NASH Clinical Research Network, Biopsy, Disease, AST, aspartate aminotransferase, RC799-869, Ethnic groups, Gastroenterology, NIMBLE, Non-Invasive Biomarkers of Metabolic Liver Disease (consortium), Fibrosis, Immunology and Allergy, Body mass index, medicine.diagnostic_test, Fatty liver, NAS, NAFLD Activity Score, Diseases of the digestive system. Gastroenterology, Hospitals, NPV, negative predictive value, Liver biopsy, Biomarker (medicine), Research Article, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, ADAM, A Disintegrin and Metalloproteases, NASH, non-alcoholic steatohepatitis, Reference range, Reference values, AUROC, area under the receiver operating characteristics curve, Internal medicine, ALT, alanine aminotransferase, Internal Medicine, medicine, Humans, FIB-4, fibrosis-4, Healthy volunteers, Hepatology, ALP, alkaline phosphatase, business.industry, CLSI, Clinical and Laboratory Standards Institute, T2DM, type 2 diabetes mellitus, ELF™ test, Enhanced Liver Fibrosis test, medicine.disease, LITMUS, Liver Investigation: Testing Marker Utility in Steatohepatitis (consortium), Collagen type III, PPV, positive predictive value, Reference standards, business, Biomarkers, Non-alcoholic fatty liver disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4eefdc7b3714522d884aabf5fb9f2cTest
https://curis.ku.dk/portal/da/publications/determining-a-healthy-reference-range-and-factors-potentially-influencing-proc3--a-biomarker-of-liver-fibrosisTest(c941fd32-bad0-4d92-b259-f5dc9c239ed9).html -
7
المؤلفون: Alan Finnegan, George Morgan, Jamie O'Hara, Gabriel Pedra, Manuel Romero-Gómez, Vanessa Hebditch, Mzwandile A. Mabhala, Tatjana Reic, Vlad Ratziu, Jörn M. Schattenberg, Bethany Franks, Elisabetta Bugianesi, Harpal Dhillon, Bengt Jönsson, Quentin M. Anstee, Leonardo Ruiz-Casas, Ingo Van Thiel
المصدر: JHEP Reports, Vol 2, Iss 5, Pp 100142-(2020)
JHEP Reportsمصطلحات موضوعية: HRQoL, health-related quality of life, medicine.medical_specialty, OTC, over-the-counter, CRF, case record form, Cross-sectional study, NASH, non-alcoholic steatohepatitis, NAFL non-alcoholic fatty liver NAFLD, non-alcoholic fatty liver disease, PPIE, Patient Public Involvement Engagement, Disease, GAIN, Global Assessment of the Impact of NASH, CLDQ, Chronic Liver Disease Questionnaire, EU5, five European, Indirect costs, Quality of life, Internal Medicine, Immunology and Allergy, Medicine, CLDQ-NAFLD, Chronic Liver Disease Questionnaire – Non-Alcoholic Fatty Liver Disease, lcsh:RC799-869, Socioeconomic status, Non-alcoholic steatohepatitis, Hepatology, business.industry, Public health, Fatty liver, Gastroenterology, T2DM, type 2 diabetes mellitus, medicine.disease, FIB-4, Fibrosis-4, Europe, Cross-sectional studies, Cost of illness, lcsh:Diseases of the digestive system. Gastroenterology, Steatohepatitis, business, Research Article, Demography
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a552c43cf8319fd28ae533dd1be81a92Test
http://hdl.handle.net/2318/1804849Test -
8
المؤلفون: Giacomo Germani, Chiara Becchetti, Patrizia Burra
المصدر: Burra, Patrizia; Becchetti, Chiara; Germani, Giacomo (2020). NAFLD and liver transplantation: Disease burden, current management and future challenges. JHEP reports, 2(6), p. 100192. Elsevier 10.1016/j.jhepr.2020.100192 <http://dx.doi.org/10.1016/j.jhepr.2020.100192Test>
JHEP Reportsمصطلحات موضوعية: medicine.medical_treatment, Review, Disease, Liver transplantation, DPP-4, dipeptidyl peptidase-4, Solid organ transplantation, GLP1 RAs, glucagon-like peptide-1 receptor agonists, mTORi, mammalian target of rapamycin inhibitors, DM, diabetes mellitus, MAFLD, metabolic dysfunction-associated fatty liver disease, Immunology and Allergy, 610 Medicine & health, Non-alcoholic steatohepatitis, Immunosuppressant, Metabolic complication, Fatty liver, Gastroenterology, Graft survival, Immunosuppression, Hypertension, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, IRR, incidence rate ratio, Diabetes mellitus, Internal Medicine, medicine, Obesity, CNI, calcineurin inhibitors, Intensive care medicine, Disease burden, UNOS, United Network for Organ Sharing, Hepatology, business.industry, CKD, chronic kidney disease, ELTR, European Liver Transplant Registry, Odds ratio, medicine.disease, HR, hazard ratio, SGLT2, sodium-glucose co-transporter-2, OR, odds ratio, ESLD, end-stage liver disease, New-onset diabetes after transplantation, Patient survival, Steatohepatitis, HCC, hepatocellular carcinoma, business, LT, liver transplant, Non-alcoholic fatty liver disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b92b01a96954af5a17961262b54974fTest
-
9
المؤلفون: Jérôme Boursier, Emmanuel Tsochatzis
المساهمون: Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)
المصدر: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100219. ⟨10.1016/j.jhepr.2020.100219⟩
JHEP Reportsمصطلحات موضوعية: Cirrhosis, Cost effectiveness, [SDV]Life Sciences [q-bio], NICE, National Institute of Clinical Excellence, Nice, Review, AST, aspartate aminotransferase, Disease, Patient pathway, ELF, enhanced liver fibrosis, 0302 clinical medicine, Immunology and Allergy, Medicine, NFS, NAFLD fibrosis score, ALD, alcohol-related liver disease, ComputingMilieux_MISCELLANEOUS, computer.programming_language, 0303 health sciences, NAS, NAFLD activity score, Case-finding, Fatty liver, Gastroenterology, Awareness, Primary care, TE, transient elastography, 3. Good health, Screening, FIB-4, 030211 gastroenterology & hepatology, Elastography, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, Liver fibrosis, QALY, quality-adjusted life year, 03 medical and health sciences, ALT, alanine aminotransferase, Type 2 diabetes mellitus, NIT, non-invasive test, Internal Medicine, GP, general practitioner, FIB-4, fibrosis-4, Intensive care medicine, 030304 developmental biology, Hepatology, business.industry, Type 2 Diabetes Mellitus, T2DM, type 2 diabetes mellitus, medicine.disease, Quality-adjusted life year, Cost-effectiveness, Transient elastography, business, computer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998a5dc5ae8854bb83716af6e6873dc7Test
https://doi.org/10.1016/j.jhepr.2020.100219Test -
10
المؤلفون: Yemi Oluboyede, Gulnar Fattakhova, Lorraine McSweeney, Luke Vale, Lynda C. Doward, Fiona Beyer, Clifford A. Brass, Quentin M. Anstee, Matthew Breckons, Laura Ternent, Maria-Magdalena Balp, Arun J. Sanyal
المصدر: JHEP Reports
JHEP Reports, Vol 2, Iss 3, Pp-(2020)مصطلحات موضوعية: medicine.medical_treatment, Disease, Liver disease, 0302 clinical medicine, Immunology and Allergy, 030212 general & internal medicine, Non-alcoholic steatohepatitis, education.field_of_study, Gastroenterology, PRO, patient-reported outcome, LDSI, liver disease symptom index, 3. Good health, health-related quality of life, Cirrhosis, 030211 gastroenterology & hepatology, Patient-reported outcome, SF-36, short form health profile 36, Research Article, FDA, United States Food and Drug Administration, RI, researcher interpretation, HRQoL, health-related quality of life, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, SF-36, NASH, non-alcoholic steatohepatitis, Population, liver, digestive system, Support group, MS, multiple sclerosis, 03 medical and health sciences, Quality of life (healthcare), NAFLD, PHAQ, patient-reported outcome measurement information system health assessment questionnaire, Internal Medicine, medicine, NAFL, non-alcoholic fatty liver, CLDQ, chronic liver disease questionnaire, lcsh:RC799-869, Intensive care medicine, education, patient-reported outcome measures, Hepatology, business.industry, nutritional and metabolic diseases, medicine.disease, QoL, quality of life, Mental health, digestive system diseases, FIS, fatigue impact scale, PROM, patient-reported outcome measure, EMA, European Medicines Agency, COSMIN, The COnsensus-based Standards for the selection of health Measurement INstruments, lcsh:Diseases of the digestive system. Gastroenterology, business, LDQoL, liver disease quality of life questionnaire
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee751f2b6ffd99b10142118b951f0fcdTest
https://doi.org/10.1016/j.jhepr.2020.100099Test